Historic $3 Billion Settlement Reached With GlaxoSmithKlineGlobal health care giant GlaxoSmithKline LLC (GSK) agreed to plead guilty and to pay $3 billion to resolve its criminal and civil liability arising from the company's unlawful promotion of certain prescription drugs, its failure to report certain safety data, and its civil liability for alleged false price reporting practices, the Justice Department announced today. The resolution is the largest health care fraud settlement in U.S. history and the largest payment ever by a drug company. In addition to the criminal and civil resolutions, GSK has executed a five-year Corporate Integrity Agreement (CIA) with OIG. The plea agreement and CIA include novel provisions that require that GSK implement and/or maintain major changes to the way it does business. "Our five-year integrity agreement with GlaxoSmithKline requires individual accountability of its board and executives," Inspector General Daniel R. Levinson said. "For example, company executives may have to forfeit annual bonuses if they or their subordinates engage in significant misconduct, and sales agents are now being paid based on quality of service rather than sales targets." Corporate Integrity Agreements ReleasedOIG updated its list of Corporate Integrity Agreements (CIA) today, adding the GlaxoSmithKline CIA as well as five others. OIG Update PodcastMike Kane, Office of External Affairs, discusses OIG's June activities, including a report on vulnerabilities in the CDC's Vaccines for Children program and the capture of two Most Wanted fugitives. That's all we have for today. If we can be of any further assistance, please send an email to public.affairs@oig.hhs.gov Dee Ellison - Office of External Affairs OIG’s privacy policy can be found at http://oig.hhs.gov/notices/privacy-notice.asp
Follow us on Twitter: http://twitter.com/OIGatHHS Inquiries? Contact us: Public.Affairs@oig.hhs.gov Manage your OIG subscriptions: update your preferences or unsubscribe Questions about this service? Support@GovDelivery.com
|
Historic $3 Billion Settlement Reached With GlaxoSmithKline
